Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin

Cell Proliferation

Volumn 44, Issue 4, 2011, Pages 343-351

  Ward, M ^a   Ajuwon, K M ^a  

^a Purdue University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; DECORIN; FIBRONECTIN; GAG PROTEIN; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; REGULATORY MECHANISM;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; APOPTOSIS; BIGLYCAN; CELL PROLIFERATION; CELLS, CULTURED; DECORIN; FIBRONECTINS; HUMANS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; OBESITY;

EID: 79959743186     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00763.x     Document Type: Article

References (34)

1. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ (2001) The biology of white adipocyte proliferation. Obes. Rev. 2, 239-254.
2. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C et al. (2008) Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 117, 806-815.
3. Henegar C, Tordjman J, Achard V, Lacasa V, Cremer I, Guerre-Millo M et al. (2008) Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 9, R14.
4. Kolehmainen M, Salopuro T, Schwab US, Kekäläinen J, Kallio P, Laaksonen DE et al. (2007) Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int. J. Obes. Relat. Metab. Disord. 32, 292-303.
5. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N et al. (2008) Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29, 1575-1591.
6. Halberg N, Wernstedt I, Scherer PE (2008) The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. North Am. 37, 753-768.
7. McEwan PA, Scott PG, Bishop PN, Bella J (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J. Struct. Biol. 155, 294-305.
8. D'Antoni ML, Torregiani C, Ferraro P, Michoud M, Mazer B, Martin JG et al. (2008) Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis, Am. J. Physiol. Lung Cell Mol. Physiol. 294, L764-L771.
9. Seidler D, Goldoni S, Agnew C, Cardi C, Thakur M, Owens R et al. (2006) Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J. Biol. Chem. 281, 26408-26418.
10. Merline R, Lazaroski S, Babelova A, Tsalastra-Greul W, Pfeilschifter J, Schulter K et al. (2009) Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J. Physiol. Pharmacol. 60, 5-13.
11. Schaefer L, Beck KF, Raslik I, Walpen S, Mihalik D, Micegova M et al. (2003) Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells. J. Biol. Chem. 278, 26227-26237.
12. Nadler S, Stoehr J, Schueler K, Tanimoto G, Yandell B, Attie A (2000) The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA 97, 11371-11376.
13. Bolton K, Segal D, McMillan J, Jowett J, Heilbronn L, Abberton K et al. (2008) Decorin is a secreted protein associated with obesity and type 2 diabetes. Int. J. Obes. 32, 1113-1121.
14. Ajuwon K, Spurlock M (2005) Palmitate activates the NF-κB transcription factor and induces IL-6 and TNFα expression in 3T3-L1 edipocytes. J. Nutr. 135, 1841-1846.
15. Cho YY, Tang F, Yao K, Lu C, Zhu F, Zheng D et al. (2009) Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation. Cancer Res. 69, 272-281.
16. Hotamisligil G (2006) Inflammation and metabolic disorders. Nature 444, 860-867.
17. Molina H, Yang Y, Ruch T, Kim J, Mortensen P, Otto T et al. (2009) Temporal profiling of the adipocyte proteome during differentiation using a 5-plex SILAC based strategy. J. Proteome Res. 8, 48-58.
18. Smas C, Sul H (1993) Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73, 725-734.
19. Rosen E, MacDougald O (2006) Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885-896.
20. El-Deiry WS (2003) The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22, 7486-7495.
21. Gartel AL, Radhakrishnan SK (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65, 3980-3985.
22. Knudsen K, Diehl J, Haiman C, Knudsen E (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25, 1620-1628.
23. Keophiphath M, Achard V, Henegar C, Rouault C, Clement K, Lacasa D (2009) Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol. Endocrinol. 23, 11-24.
24. Wang C, Mayo M, Baldwin A Jr (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
25. Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E et al. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 106, 1221-1228.
26. Rasouli N, Molavi B, Elbein SC, Kern PA (2007) Ectopic fat accumulation and metabolic syndrome. Diabetes Obes. Metab. 9, 1-10.
27. Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 28, S12-S21.
28. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295.
29. Mariman E, Wang P (2010) Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell. Mol. Life Sci. 67, 1277-1292.
30. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF et al. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J. Biol. Chem. 284, 24035-24048.
31. De Luca A, Santra M, Baldi A, Giordano A, Iozzo R (1996) Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem. 271, 18961-18965.
32. Santra M, Mann D, Mercer E, Skorski T, Calabretta B, Iozzo R (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100, 149-157.
33. Spiegelman BM, Ginty CA (1983) Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 35, 657-666.
34. Hannes EG, Hobert O (2006) The molecular diversity of glycosaminoglycans shapes animal development. Annu. Rev. Cell Dev. Biol. 22, 375-407.